Search

everythinglearnresearchcommunity

for

Search:↓

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Invasomes effectively deliver drugs through the skin and have potential for improved treatments.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

Accidental findings have led to new hair treatment discoveries, like using blood pressure and diabetes medications for hair loss and unwanted hair.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

NFATc1 is crucial for keeping hair follicle stem cells inactive.

Dermal papilla microtissues could be useful for initial hair growth drug testing.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

A dog developed a skin condition called pemphigus foliaceus after taking NexGard, but got better with treatment.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Adding soybean oil to Nonomuraea dietziae increases production of a beneficial compound by improving metabolism and enzyme systems.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.